NCT00414193View on ClinicalTrials.gov

Piperacillin/Tazobactam for Bacteremia With Organisms Producing Chromosomally-Encoded AmpC Beta-Lactamase

CompletedOBSERVATIONAL
Enrollment

1,000

Participants

Timeline

Start Date

February 28, 2007

Primary Completion Date

December 31, 2017

Study Completion Date

December 31, 2017

Conditions
BacteremiaAmpC Beta-lactamase
Trial Locations (1)

15213

University of Pittsburgh Medical Center, Pittsburgh

Sponsors
All Listed Sponsors
collaborator

Japan Health Sciences Foundation

UNKNOWN

lead

University of Pittsburgh

OTHER